P

Inventor

SPIEGEL DAVID

US29 patents
⚠️ This page may combine multiple inventors who share the name “SPIEGEL DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV YALE

23 patents
US10066026B2Sep 4, 2018

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE11 citations92
US9556167B2Jan 31, 2017

TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)

UNIV YALE22 citations92
US9296708B2Mar 29, 2016

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE17 citations92
US11725064B2Aug 15, 2023

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE6 citations85
US11014992B2May 25, 2021

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE8 citations83
US10703823B2Jul 7, 2020

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE9 citations83
US10016412B2Jul 10, 2018

TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs)

UNIV YALE6 citations82
US10703743B2Jul 7, 2020

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

UNIV YALE1 citations73
US10030008B2Jul 24, 2018

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

UNIV YALE2 citations73
US12083181B2Sep 10, 2024

Bi-functional molecules to degrade circulating proteins

UNIV YALE4 citations72
US11767301B2Sep 26, 2023

Bi-functional molecules to degrade circulating proteins

UNIV YALE4 citations72
US12485178B2Dec 2, 2025

Bifunctional small molecules to target the selective degradation of circulating proteins

UNIV YALE1 citations62
US12084517B2Sep 10, 2024

Chimeric small molecules for the recruitment of antibodies to cancer cells

UNIV YALE0 citations62
US11858917B2Jan 2, 2024

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

UNIV YALE0 citations62
US11136316B2Oct 5, 2021

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the Human Immunodeficiency Virus

UNIV YALE0 citations62
US10188727B2Jan 29, 2019

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

UNIV YALE0 citations52
US12364766B2Jul 22, 2025

Bifunctional small molecules to target the selective degradation of circulating proteins

UNIV YALE0 citations50
US12234256B2Feb 25, 2025

Molecular degraders of extracellular proteins

UNIV YALE0 citations44
US12128105B2Oct 29, 2024

Molecular degraders of extracellular proteins

UNIV YALE0 citations44
US9745334B2Aug 29, 2017

Cytotoxic-drug delivering molecules targeting HIV (CDM-Hs), cytotoxic activity against the human immunodeficiency virus and methods of use

UNIV YALE0 citations41
US10780084B2Sep 22, 2020

Antibody-recruiting molecules for the treatment of cancer

UNIV YALE0 citations38
US10633374B2Apr 28, 2020

Small molecule based antibody-recruiting compounds for cancer treatment

UNIV YALE0 citations33
US10526339B2Jan 7, 2020

Substituted glucosepanes and compositions thereof

UNIV YALE0 citations30

SPIEGEL DAVID

5 patents

PT Worldwide

1 patent